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MRI for fetal developmental brain abnormalities: perspectives 
from the pregnant patient 
Abstract 
Ultrasound is routinely used as a prenatal screening and diagnostic tool but has 
limitations. Some anomalies in the developing fetal brain can be difficult to detect, and 
in utero MRI (iuMRI) is increasingly used as an adjunct to ultrasound. However, 
understandings of patient perspectives of iuMRI technology are still developing. Our 
qualitative study of 41 mothers who experienced iuMRI was embedded in a diagnostic 
accuracy trial, and aimed to inform policy recommendations that might stem from the 
clinical findings. Our analysis suggests that iuMRI is seen as useful, offering valuable 
additional information, and helping women make decisions about care options at a 
difficult time. However, patients’ experiences demonstrated the uncertainty and anxiety 
associated with the prenatal diagnosis (PND) process relating to brain anomalies 
including the challenges of their embodied contributions. Our findings suggest more 
could be done to reduce the impact on pregnant women during an already difficult, 
anxious period. 
ISRCTN (http://www.isrctn.com/) 
Registration number: 27626961 
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Background 
From the early 1990s ultrasound scanning (US) developed to become the standard 
method of detecting fetal structural abnormalities (Getz & Kirkengen, 2003) and it is 
now a routine part of antenatal care. In the UK, US is routinely offered at 18-20 weeks 
(NHS Fetal Anomaly Screening Programme, 2015) and includes screening for brain 
abnormalities. Despite improving techniques, sonographers still face factors that impact 
on the quality of imaging (e.g. position of the fetus (fetal lie); physical characteristics of 
the mother). Anomalies in the developing fetal brain can be subtle, difficult to detect, 
and open to clinical interpretation (Bijma, Wildschut, van der Heide, van der Maas, & 
Wladimiroff, 2004; Blondiaux & Garel, 2013). The development of methods of 
acquiring MR data very quicklyi has led the way to magnetic resonance imaging (MRI) 
of the fetus, including the fetal brain. In utero MRI (iuMRI)ii has overcome problems 
presented by fetal lie and maternal body shape, while the development of ultrafast 
imaging methods negates many of the obstacles associated with fetal movement. IuMRI 
of fetal brain abnormalities is a clinically useful adjunct to diagnostic ultrasound from 
as early as 18 weeks gestational age (Blondiaux & Garel, 2013; Griffiths et al., 2017; 
Saleem, 2013); in cases of apparently isolated ventriculomegaly (VM)iii diagnosed by 
US, iuMRI has been shown to increase the detection of other brain abnormalities 
particularly agenesis of the corpus callosumiv (Blaicher et al., 2003). IuMRI thus has the 
potential to influence clinical management (Griffiths et al., 2017; Saleem, 2013).  
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Questions of accuracy and clinical utility of US and iuMRI in prenatal diagnoses raise 
queries about the impact of new healthcare technologies on patients, in a complex area 
of health care provision. Decision-making following a diagnosis of fetal abnormality 
generates significant research and debate about the emotions and dilemmas that parents 
and clinicians encounter. Parents report being ill-prepared for a prenatal diagnosis 
(Ahman, Runestam, & Sarkadi, 2010; Lalor & Begley, 2006; Mitchell, 2004) and 
clinicians face complex ethical decisions and may experience personal conflicts (Garel, 
Gosme-Seguret, Kaminski, & Cuttini, 2002). Getz and Kirkengen (2003) highlight the 
importance of distinguishing between technology development and technology 
implementation in prenatal diagnosis, and argue for more research into parents’ 
experiences. For example, in a qualitative study of prenatal US experience, researchers 
found that sonographers’ behaviour figured prominently in women’s accounts of  
experiencing an unexpected fetal diagnosis (Van der Zalm & Byrne, 2006). More 
recently, an ethnographic study of a fetal medicine clinic employing iuMRI suggested 
that clinical uncertainty could be positively mediated by the radiologist’s use of the 
technology (Reed, Kochetkova, & Whitby, 2016). Reed et al (2016) note in their 
conclusion that health professionals see iuMRI images as a bridging technology that 
aided translation across medical specialties, but also assisted clinicians in counselling 
patients.  
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Understanding how patients experience the process is ethically imperative if proposing 
changes in clinical practice. Williams et al (2006) in particular have raised concerns 
about how new technologies in fetal medicine tend to emerge into clinical practice prior 
to understanding the broader consequences for patients. An early study of 32 women 
undergoing iuMRI found that while ultrasonography was preferred, most patients felt 
relaxed and comfortable (Duncan, Baker, Johnson, & Gowland, 1996). More recent 
findings suggest that iuMRI is more stressful than US; a prospective questionnaire study 
of 100 patients (Adamsbaum, Garel, & Legros, 2008) found that iuMRI increased 
anxiety by its setting and the uncertainties about fetal risk. Another study (Leithner, 
Pörnbacher, Assem-Hilger, Krampl-Bettelheim, & Prayer, 2009; Leithner et al., 2008) 
reported that 58% of 62 women interviewed were concerned by the intensified fetal 
body movements in response to the noisev and vibration during the scan. Nevertheless, 
overall 63% reported that iuMRI was ‘easy to tolerate’ and a follow-up study of 36 
women one year after the investigation (Leithner et al., 2013) reported that acceptance 
of iuMRI was very high. However, for some women, the noise, physical restraints, and 
duration of the examination (Leithner et al., 2008) seemed to have lasting effects in the 
form of enduring psychological distress (Leithner et al., 2013).  
MERIDIAN is a diagnostic accuracy trial funded by the UK National Institute for 
Health Research (NIHR) Health Technology Assessment Programme [project number 
09/06/01] to assess iuMRI as a technology to aid in the prenatal diagnosis of fetal 
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developmental brain abnormalities. The clinical trial was complemented by an 
economic analysis of provision, and a qualitative study of patient and health 
professional experiences of receiving and providing iuMRI. The clinical study 
encompassed many clinical units across the UK, offering a unique opportunity to 
explore the impact of introducing new or revised care pathway developments in 
practice, and the feasibility of further policy development for iuMRI provision in the 
UK. The qualitative study was made up of three parts, each involving the collection of 
primary data. Part 1 involved asking all patients to complete two questionnaires (Survey 
One shortly after a decision about the affected pregnancy having been made; Survey 
Two some weeks after pregnancy completion). Part 2 involved interviewing a sub-
section of those who completed the surveys, where participants could express an interest 
in taking part at the end of Survey Two. Part 3 involved interviewing health 
professionals providing iuMRI, in the first and third year of recruitment to the clinical 
study.   
In this article we report the results of the qualitative interviews with patients. Our 
findings explore women’s embodied experiences of iuMRI in their accounts of 
receiving prenatal diagnosis care. Whilst iuMRI is of interest to social scientists for 
many reasons, we wanted to focus on women’s experiences first, and then to determine 
where iuMRI fits into the bigger picture for the women interviewed. Drawing on 
existing sociological literaturevi, we explore the complexity of women’s experiences 
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evident in data from in-depth interviews. Our aim was to explore whether iuMRI 
offered meaningful benefits for these pregnant women, and whether their experience of 
the procedure could be improved.  
Research context and methods 
(i) The clinical context: In the UK (NHS England, 2013) ultrasound screening  is 
offered to women at 11-14 and 18-20 weeks of pregnancy. If an anomaly is identified or 
suspected, the woman is referred to a second sonographer or consultant, and (if the 
woman consents to it) referral to an in-house consultant with fetal medicine experience 
or to a specialised fetal medicine unit (FMU). If an anomaly is confirmed, the patient 
may be offered relevant prenatal investigations such as maternal blood-testing, 
karyotyping/chromosomal microarray, or iuMRI where available. Within the UK 
National Health Service, this care pathway is publicly funded. Women’s iuMRI 
experience differs from ultrasound. Not all clinicians choose to make use of (or have 
easy access to) iuMRI, so provision is variable. Then, during the scan, women have to 
remain still for 20-40 minutes, lying on their back in a confined space. The imaging 
process can be loud, warm, claustrophobic and/or uncomfortable, particularly as 
pregnancy advances. Understanding women’s experiences of this care is important in 
informing future policy, given that comprehensive national provision of iuMRI is still 
developing.  
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The MERIDIAN study is a multi-centre prospective observational study of the 
diagnostic accuracy of iuMRI for fetal developmental brain abnormalities. The study 
recruited women with an US diagnosis of a fetal brain abnormality from 16 FMUs in 
the UK between 2011 and 2015. Recruited women attended one of six centres for their 
iuMRI.  
(ii) The research project context: The clinical study included a three-part social 
scientific qualitative element exploring patient and professional experiences of iuMRI 
as part of the prenatal diagnosis pathway for brain anomalies. The aims of the parent 
experience aspect of the qualitative study were: 
1. To describe, explore and understand how women (and their partners/relatives) 
experience an iuMRI scan as part of the fetal diagnosis care pathway 
2. To give an account of perceptions of iuMRI on decision making 
3. To gain insights into the impact of developments in technology and medical 
knowledge 
The purpose therefore of this parent-focused part of the qualitative study was to 
complement the clinical study, by looking at women’s experiences of the prenatal 
diagnosis experience from a more critical, social science perspective. Currently iuMRI 
in antenatal care is variable in how it is managed and deliveredvii, and future policy on 
iuMRI provision is likely to reduce variability in provision. Our research explores a 
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range of women’s experiences, from different care pathways, to inform any policy 
developments stemming from clinical efficacy studyviii. 
Approval for the sub-study was obtained from the UK NHS South Yorkshire Research 
Ethics Committee (Dated 3 March 2011, Ref 11/YH/0006). Women were approached 
for the qualitative study after recruitment to the trial, following the initial iuMRI and 
counselling. Particular care was taken that women had enough time after the pregnancy 
outcome to consider participation before written consent was taken. Because of the 
sensitivity of the topic, research midwives were allowed discretion about whether and 
how to approach individual women especially if they had suffered pregnancy loss soon 
after their iuMRI. Following entry to the qualitative study, women were given a survey 
questionnaire collecting socio-demographic data, overall satisfaction with care, and 
perceived utility of the iuMRI results. A second questionnaire was administered three to 
six months after the pregnancy outcome was known. This included an open text 
question to allow participants to raise issues they felt important to their health care 
experience; and a filter question to allow women to express an interest (EOI) in taking 
part in a qualitative in-depth interview. We received 108 EOIs from 14 FMUs. We drew 
on the questionnaire and clinical data about research participants to generate a 
sufficiently diverse sample for the interviews. This was needed because the study 
findings were intended to inform policy developments, should the clinical case for 
expanding access to iuMRI be found valid at the end of the clinical trial.ix Initially the 
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sampling strategy for interviews covered three specific FMUs representing different 
models of iuMRI provision (iuMRI provided locally; iuMRI provided at a central 
iuMRI site where patients travel; or a hybrid model with both local and regional 
iuMRI).  We added a fourth sub-group to the interview sample, made up of patients 
from several of the smaller FMUs, to further enhance understandings of patient 
experience of centralised technology in the context of secondary level (rather than 
tertiary level) care provision. The sample for the interview study was therefore diverse 
in that it encompassed participants from different types of care pathway. Because a 
small number of sites were added towards the end of the trial and after the survey 
closed, there was representation from only 13 of the 16 FMUs, and 3 out of 6 of the 
MRI centres. 
The ultrasound diagnosis, participant’s age, gestation at MRI scan, and outcome were 
also considered in the course of sampling from trial data (see Table 1 in supplementary 
file). Gravidity and parity were not available to be included because they were not 
directly relevant to the primary and secondary outcomes of the trial.  
(iii) The parent interview data collection process: As the researcher responsible for the 
qualitative study of patients, Mabel Lie had password protected access to relevant 
sections of the central database managed by the MERIDIAN study team at the Sheffield 
University Clinical Trials Research Unit (CTRU).  
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Altogether forty-four interviews were conducted between September 2012 and 
December 2013. Twenty-five women were interviewed individually, 16 were joint 
interviews with partners or mothers mainly to support them (Zarhin, 2018), while two 
interviews were conducted with partners on their own. An additional interview was with 
a partner who requested that his wife (who had been interviewed separately) be present 
with him. Interviews were conducted in participants’ homes and recorded on an 
encrypted digital voice recorder. All participants were asked to sign a separate 
qualitative interview consent form. A narrative approach to interviewing was adopted, 
allowing participants to develop their own account of their ‘story’ of their pregnancy. 
This allowed us to consider how the iuMRI experience fitted into the participant’s 
broader perspective of their antenatal care. The topic guide was used to prompt the 
participant to discuss key issues e.g. learning about the abnormality, undergoing the 
iuMRI scan, and decision making about the pregnancy, differences between US and 
iuMRI, information seeking, and support. The audio recordings of the interviewsx 
lasting between 1-2 hours, were transcribed by two research secretaries. The transcripts 
(stored on a secure server) were then checked and anonymised by Mabel, and uploaded 
into qualitative data management software (Atlas.ti) for indexing and retrieval.  
(iv) The parent interview study data analysis: In his classic text Interpreting 
Qualitative Data, Silverman (2006, p. 119) outlines a threefold typology of positivism, 
emotionalism and constructionism as frameworks for analysing qualitative interview 
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data. Of particular interest to us is his analytic distinction between an emotionalist 
approach (which aims to understand authentic experiences), and the constructionist 
approach (which assumes that meaning in the data is mutually constructed). Our 
approach encompasses elements of both emotionalism and constructionism, but 
constructionism is the more dominant element. The women we interviewed had 
experienced prenatal diagnosis of a brain anomaly, and then iuMRI as part of the PND 
process, which is not universally available to all women whose baby is at risk of a brain 
anomaly. They therefore had a unique perspective to offer us, but such perspectives are 
difficult to access because prenatal diagnosis is a sensitive topic. The authentic 
experience that Silverman (2006) characterises as associated with emotionalism was 
important to us, but we aimed to take the authenticity expressed in interviews and 
reflect on it as socially constructed and contextualised. Constructionist thought drives 
the analysis, but it contains elements associated with a more emotionalist approach, 
creating analytic tensions that were ultimately productive.   
The semi-structured interview transcripts allowed us to start our analysis from women’s 
experiences of the relative importance of iuMRI in the context of the prenatal diagnosis 
pathway overall, rather than leading the interview with our interests in iuMRI. 
Information was also collected on key aspects that are important from a policy 
perspective that would be part of any future policy work in iuMRI provision.  
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Our work is informed by two strands of medical sociology thinking. First, our approach 
draws inspiration from Frank’s (1995) notion of illness narratives. Secondly, the strand 
of work that focuses on embodied experience was also important, given the emphasis in 
women’s accounts of their embodied experiences during the scanning process. These 
perspectives provide an element of ‘standpoint’ epistemology (Harding, 1991) to the 
analysis. This blend of theoretical influences maps well to the complexities of iuMRI in 
the context of prenatal diagnosis of brain anomalies. The narrative elements allow us to 
contextualise the phenomenon of iuMRI as part of a much more complex process, but 
foregrounding embodied experiences, to represent and evaluate women’s experiences 
on their own terms. At the same time, the more interrogative aspects of viewing 
abnormality as socially constructed allows us to more fully explore the inherent 
uncertainties associated with prenatal diagnostic categories. Together, these theoretical 
influences provide a framework that encompasses the analysis of both representations of 
highly personalised experiences alongside a critically interrogative exploration of 
patterns of meanings.  
Given this blend of theoretical influences, we used thematic analysis as the practical 
framework with which to conduct the formal analysis of the data. Thematic coding is 
used in a variety of theoretical traditions, so it is well suited to the demands of our blend 
of theoretical influences. Drawing on the six stage process set out by Braun and Clarke 
(2006), we analysed the interview data to encompass both the emotional and embodied 
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standpoints of participants as well as our interpretations of their socially constructed 
perspectives of the value and role of iuMRI. 
The interview transcripts were grouped according to MRI centre and pregnancy 
outcome. A generative thematic analysis (Braun & Clarke, 2006, 2014) and an 
inductive-abductive strategy influenced by grounded theory (Charmaz, 2006) was used 
to interrogate the data. Gerunds were employed as codes, which were grouped into 
thematic families. Codes within these families were checked for consistency, and 
compared for similarities and differences across families. Broader themes were then 
developed from these codes to make up the overall thematic framework (Charmaz, 
1983, 2006). Synopses of each interview were composed by Mabel, and read by Ruth 
Graham for an overview of all the interview cases. In addition, data meetings within the 
sub-study team (Ruth, Mabel and Stephen Robson) provided a qualitative form of inter-
rater reliability (Silverman, 2006) for the coding frame and interpretive analysis. The 
thematically organised data were then used as the basis of an interdisciplinary meeting 
with the wider study team members, to review the final thematic framework.  
As the descriptive coding framework developed and remained stable following 
additional interview data, recruitment was ceased. Theme summaries were developed 
(led by Mabel with input from Ruth). Relatively descriptive themes were refined and re-
ordered in such a way as to begin the process of building towards a more explanatory 
perspective. This was an in-depth, systematic analysis of the interview data by the two 
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sociologists on the research team, with further refinement and sharpening of the 
thematic groupings through input from a broader group that included clinicians and 
researchers from other disciplines involved with the study to boost the pragmatic utility 
of our findings for future policy development.  
We aimed to describe and explain the role of iuMRI in the prenatal diagnosis pathway 
and its impact on the women involved, to inform decision making about future policy 
developments on the basis of a rigorous social science analysis, rather than to generate 
specific theoretical constructs about iuMRI. We present the findings of our analysis in 
this article under the three main thematic headings generated from the data: Themes 1, 2 
and 3.  
Interview study findingsxi 
Theme 1 – The subjective embodied experiences of iuMRI scanning 
The provision of the iuMRI scan varied within and between MRI centres, and was also 
impacted by issues such as women’s gestation, their BMI, and other medical problems 
e.g. diabetes. One iuMRI centre was an academic radiological unit (Site A) and had a 
different clinical protocol to the two other iuMRI sites (D and M); at Site A women had 
the opportunity to view the iuMR images directly after the scan, in discussion with the 
academic radiologist. At other sites, the iuMR images were sent to the FM specialist 
with a report and a consultation with the patient was arranged sometime after the scan. 
Here we offer an insight into the common experiences of the women across the sites. 
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The findings suggest that the women’s subjective embodied experiences of the scanning 
process were impacted by their status as pregnant, and became more problematic as 
their gestation (and therefore size) increased.  
1.1 Willingness to tolerate emotional and physical discomfort: The iuMRI sessions 
lasted from around half an hour to over an hour. Two key issues could lengthen the 
scan: how well the individual woman tolerated the scan (and if she needed breaks); and 
how active the fetus was during the scan (which may delay the capture of accurate 
iuMR data). All the women were well aware that the purpose of undergoing the iuMRI 
was because their baby had been found to have a brain abnormality, and getting 
information to find out more about their baby’s condition was the focus of their 
concerns. As a result, they were often highly motivated to assist in achieving a 
successful scan, despite their anxiety and discomfort:  
..because it was [Baby] everything became more scary and more frightening and 
more upsetting even though I knew I was perfectly safe and I knew there was no 
risk to him, it was still the ‘I’m really scared about what it’s going to show’ [ ] 
and rather than the actual thing itself so….…..had I been pregnant with [Baby] 
and [Baby] was perfectly healthy, I probably wouldn’t have been that bothered.  
It was more the fact that I knew he wasn’t well – (Site D, 19 weeks, IVM)xii 
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In most of the women’s accounts, descriptions of their discomfort appeared to be related 
to their pregnant condition, which was exacerbated by the noise, heat, and enclosed 
space in the machine: 
…when you are pregnant, I think, I think when I’m pregnant I’m a much more 
erm, sort of spatially sensitive.  I need my own space a lot more.  [ ] Probably 
hormonal - (Site D, 22 weeks, nVM) 
Challenging experiences in the iuMRI scanner were more common in those who were 
over 24 weeks’ gestation. Not only did their increased girth lead to more discomfort but 
the emotional impact of being in a tightly enclosed space could lead to additional 
anxiety:   
But that was the only problem that I had like it was I felt very, I felt unsafe if you 
know what I, but I’m sure that any, anybody who’s that’s heavily pregnant going 
in to a machine like that and you know feeling like you’re gonna get trapped in 
there cos you’ve got such a big belly – (Site A, 36 weeks, IVM) 
Women described their experience of pain because of how cramped they were in the 
machine or because of pregnancy-related pelvic pain. This was exacerbated by the 
‘frame’ that was placed across their abdomenxiii  
But it was quite uncomfortable and I had to lie on my back which was very painful 
and then they had the, the cage thing over my stomach which was quite heavy and 
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it was very uncomfortable and it was very hot and I was still having morning 
sickness it was just…. – (Site M, 32 weeks, nVM) 
The majority of women strived to keep as still as possible so that the data for the images 
could be obtained as quickly as possible. A few were concerned about the noise being 
harmful to their fetus. Most women described actively resisting the urge to come out of 
the scanner and tolerated any discomfort they experienced, because taking a break 
would only delay the process:  
There were headphones and music, I remember that and I was given a button to 
press.  I spent the whole time trying to make myself not press the button.  Tried to 
last as long as I could [laugh].  – (Site D, 22 weeks, IVM) 
These accounts point to the extent of the discomforts of being in the machine and the 
way women tolerated them, which can often be overlooked in the diagnostic process.  
1.2 Aids to tolerating discomfort: Some women described ways in which their intense 
experience of the iuMRI scan became more tolerable.  For example, women were 
particularly grateful for their partner’s presence during the scan: 
….allowing [Husband] in there to like, have a hold of my hand and stroke my 
hair, well all he could reach was my hair so he was patting my head, … made it a 
much more tolerable experience. – (Site D, 19 weeks, IVM) 
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Other instances included interaction with health professionals during the scan. For 
example, some participants reflected on how the radiographer helped to make them 
comfortable, and briefed them about the procedure before and during the scan via the 
headphones:   
no it was a bit strange experience but it wasn’t unpleasant or pleasant.  It was just 
a different experience for the first time……. And then it went du, du, du, du, du, 
du, du, du.  Right we are blasting off in a minute.  We were making jokes kind of 
thing.  …  It didn’t upset me or scare me or anything. – (Site M, 23 weeks, IVM) 
Women who were less advanced in their pregnancy seemed to have had a more positive 
experience of being in the scanner. For example, even though Emma (22 weeks) 
suffered pelvic pain which caused her discomfort, she managed to fall asleep in the 
scanner. Sue (20 weeks) who was used to running around looking after her three year 
old, described the experience of lying in the machine as restful, while Sarah (25 weeks) 
felt the vibrations were like a massage in bed.  
In general, women were willing to undergo discomfort because of the concern for their 
baby, and their desire to get more information. The following was a typical response: 
I think again because you’re focussed on, because you are worried about your 
baby, again I think I would have gone in a much smaller tunnel through the water 
if necessary – (Site A, 29 weeks, IVM) 
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Nevertheless, the narratives point to the subjective embodied experiences of different 
women who share the common condition of being pregnant and desperate to know if 
their baby has a serious problem. Pregnancy-related conditions especially 
musculoskeletal pain can heighten negative experiences of the procedure. Further, 
perceptions that fetuses reacted to the noise of the scanner provoked anxiety in some 
women. To balance these accounts of women’s physical and emotional experiences of 
iuMRI, we now consider women’s motivation for undergoing the scan. 
Theme 2 – Negotiating the developmental uncertainty of fetal diagnosis  
The diagnosis and counselling of a fetal brain abnormality is challenging partly because 
of the multiple pathologies that can co-exist but also because ‘developmental’ brain 
abnormalities can change or evolve over gestation (Hannon et al., 2012; Sethna, 
Tennant, Rankin, & Robson, 2011). Coupled with this are the differing skills and 
knowledge of the health care professionals involved (Prasad, 2005). This area of 
medicine can become baffling for patients and their partners, as they contemplate their 
wanted pregnancy through a series of incremental steps that aim to reduce uncertainty. 
The care pathway for a fetal brain abnormality would usually include follow up US 
scans to monitor the abnormality and for some pregnancies, a second or third iuMRI at 
later gestations, with the aim of reaching a more definitive diagnosis and/or prognosis. 
However, even if a definitive diagnosis can be reached, the prognosis is often limited to 
a risk-based analysis of the probable impact on the future child.  
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2.1 Understanding and monitoring the abnormality: For most parents, the offer of an 
amniocentesis (to exclude a chromosomal abnormality) and then an iuMRI to determine 
the characteristics of the abnormality, were then followed by an emotional journey of 
monitoring scans and experiencing ongoing uncertainty about the future. For example, 
in the case of isolated VM, the initial prognosis is highly dependent on the ventricular 
size; ranging from at least a 90% chance of normal development when the ventricle 
measurement is 10-12 mm to less than 50% chance of normal development if the 
measurement is > 15 mm (Gaglioti, Oberto, & Todros, 2009). Parents understood that 
the risk to their baby depended on the ventricular measurement, which could stay the 
same, increase or decrease. For parents where the ventricular size remained constant, 
this was seen as being of less cause for alarm, but for parents where the measurements 
increased over time, it clearly represented a worsening of the condition.  
when it was diagnosed it was ten and a half and twelve and a half or something 
like that … you know one was mild and one was moderate … so the next time one 
was moderate and one was heading towards severe you know it was [ ] and when, 
we went once and it was they were both over fifteen [  ] both left and right were 
both over fifteen and I was, I cried at that one because I knew that, that was 
severe and it wasn’t decreasing it was getting worse – (Site A, 22 weeks, IVM) 
Parents described a roller coaster of emotions, especially when the measurements 
changed in a short space of time: 
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Then it was twelve point eight, nineteen … twenty eight point five and …twenty 
three [ ].  So it just got bigger and bigger and bigger and last time we had his 
MRI they said it was thirty two wasn’t it? – (Site M, 25 weeks, VM+, Infant with a 
disability) 
Because of what they understood about VM, the experience of follow-up scans, whether 
iuMRI or US, could be the most stressful part of the patient’s journey. For several 
parents, the iuMRI scan was just one appointment of many along the care pathway. In 
addition, the clarity of the imaging cannot ameliorate the inherent uncertainty of 
eventual outcome, as some infants will have a normal outcome despite having enlarged 
ventricles. 
In cases where the diagnosis was ‘non-isolated VM’, many parents described the 
experience of monitoring not only the size of the ventricles but also other structural 
abnormalities. Together with referrals to other specialists, and understanding that it 
could develop in different ways with the prognosis being uncertain, the process took a 
huge toll on parents. The majority of these cases of non-isolated VM were serious brain 
abnormalities that ended with a termination of pregnancy, a non-surviving or infant with 
a disability. As compared with VM, other fetal brain abnormalities were less common 
and often required less monitoring.   
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2.2 Understanding and tolerating uncertainty: The parents’ accounts suggested that 
whilst clinicians made some attempt at explaining the condition, they also admitted the 
limits of their own clinical understanding.  
..because the brain is such an unknown scientific thing, they can’t, there’s not 
much, you know, there’s not much research on the brain … that they couldn’t 
pinpoint anything – - (Site A, 20 weeks, IVM) 
Apart from unanswered questions as to aetiology, there was also the question of the 
long term outcome. The following case concerned the discovery of bilateral 
abnormalities (cysts and abnormal brightness [echogenicity] in the cerebral cortex of the 
frontal and occipital lobes), and attempts to understand the condition and how it was 
affecting the fetus in its development.   
They then said they didn’t know what these cysts meant so we should still go for 
the MRI because they, they didn’t know they’d not.  She hadn’t personally seen 
them before, she hadn’t even seen them in the literature. When we went to the 
MRI scanner ……. they found the cysts and they still didn’t know what they meant 
– (Site A, 29 weeks, nVM) 
But more important to parents was their need for a definitive prognosis, including what 
it could mean for the viability of the pregnancy, the baby’s postnatal development and 
how as parents they would manage: 
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I mean we were kind of saying well, how is this gonna affect my baby know like 
we don’t know [ ] we don’t know what it is, so we, we, we, we don’t have anything 
to tell you - (Site M, 32 weeks, nVM, Infant with a disability) 
Arriving at a definitive prognosis was difficult especially in the case of VM where the 
degree of abnormality could vary over time – for some, ventricles that are of abnormal 
size may return to within the normal range at a later point in pregnancy. For those 
parents who were focused on the risks associated with an abnormality (e.g. ventricle 
size), the risks are not definitive in terms of impact on prognosis, and so remain open to 
further interpretation. Where uncertainties were difficult to explain, the MRI image 
could be a useful tool to aid understanding of diagnosis and as a result explain prognosis 
in some cases. This is explored in the next theme.  
Theme 3 – Qualifying the beneficial role of the iuMRI  
Participants’ experiences of managing the uncertainties associated with PND for brain 
anomalies highlighted the contradictory role that iuMRI played in both extending, and 
limiting, the scope of uncertainty associated with the prenatal diagnosis of a brain 
abnormality in the fetus.  
3.1 Reassurance without risk: Of the 11 parents in the interview study who reported 
undergoing an amniocentesis, none had a baby with a chromosomal abnormality. As for 
parents who had decided against an amniocentesis, they seemed to place a greater 
reliance on the iuMRI findings.  
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P43, who was carrying twins, described their reliance on the iuMRI, as they decided not 
to have an amniocentesis because of the increased risks of miscarriage. The parents 
reported that the iuMRI suggested that there were no abnormalities other than VM, and 
the corpus callosum (which was not seen on US) was present. This had provided 
reassurance that the VM abnormalities were not also an ‘indicator’ of a more 
widespread problem with the baby’s brain. For these parents, the iuMRI was a crucial 
element in reducing uncertainty: 
before the MRI was done you know to be told it could be fifty, fifty or it could be 
ninety to ten you know is a big difference [].  Because they can’t say without 
having additional information of knowing if everything else is ok or if there’s 
other issues with the brain they’re not gonna know.  So you know by having the 
MRI those percentages made more of a sense erm before the percentage you 
might as well of just said pick a number out the air.  – (Site M, 21 weeks, IVM) 
In contrast, for those cases where the brain abnormality was likely to result in a 
disability, it was a matter of the degree of severity, rather than a question of whether 
there would be an impact on the baby. 
3.2 Limits to the acceptability of iuMRI: Parents face difficult and complex decisions 
about what is best for their baby, and their family. In such instances, the iuMRI usually 
played an important part in parental decision-making, as parents carefully weighed up 
the known and unknown aspects of their baby’s prognosis. For one participant who 
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decided to continue with her pregnancy, the iuMRI confirmed the overall brain structure 
was normal, whereas the US was only able to indicate the size of the ventricles. 
However, to some parents, the iuMRI offered information to confirm what the 
ultrasound scan revealed, but did not provide additional substantive information. 
Nevertheless it was still appreciated because it ‘confirmed what the ultrasound had 
already seen’, Mandy (Site M, 21 weeks, IVM) 
For some parents though, there was little perceived benefit as a result of the iuMRI. For 
them, the anxieties and discomfort of the iuMRI scan, together with what could be 
conceptualised as unnecessary worry, figured more prominently in their accounts of the 
PND experience overall. A minority of respondents felt they would not undertake 
iuMRI in the future, should a similar situation arise, but this minority gave important 
insights into their thinking about this possibility:  
I was massive and I got, I got crushed in there so when I come out I was crying 
[Mabel: were you crying?] yeah I got crushed so I couldn’t, I had to lie a certain 
way erm obviously with how big my belly was –  (Site M, 29 weeks, IVM) 
The following is an exchange between the couple (Site M, 20 weeks, VM+) and the 
interviewer: 
Partner  ….the MRI is an intimidating machine it’s an intimidating noise 
and you’ve got to be still  
27 
 
Patient You’ve got to keep nice and still……………………. 
Mabel do you feel like you were put through unnecessary worry? 
Patient You say that all the time don’t you [yeah] yeah.  He says it all the time. 
Some parents highlighted the fact that iuMRI was able to generate hundreds of images 
from various angles, demonstrating that they understood this was a qualitatively 
different form of imaging to US. Those at Site A were also given access to the images 
and the possibility of a video clip. These parents were also able to contrast the clarity of 
the iuMRI images with those of the US scan, which they felt contributed to greater 
accuracy and information for the clinicians. Others with an increased BMI described the 
iuMRI having the capability to obtain the images which in their experience the US had 
failed to do. This suggested that the perceived benefit of the iuMRI image was enhanced 
if parents had the opportunity to see and discuss their iuMRI with a clinician.  
Evaluating the use of health care technology is often focused on clinical outcomes using 
statistical measures of accuracy and cost effectiveness. Our data suggest that, in the case 
of iuMRI for diagnosing fetal brain abnormalities, understanding patient experiences of 
the prenatal diagnosis care pathway is an important facet in the evaluation of a new 
health care technology. While a certain amount of uncertainty is often unavoidable in 
prenatal diagnosis, the accounts from participants pointed to the benefits of iuMRI in 
providing a different type of image and offering the potential for better experiences of 
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care during a period of difficult decision making. However, a minority of parents also 
offered understandable reasons for not choosing this option again, should a similar 
situation arise.   
Discussion 
The literature on the topic of iuMRI in prenatal diagnosis is limited and confined mainly 
to clinical and psychological studies of the impact of this new technology on women 
(Adamsbaum et al., 2008; Leithner et al., 2008; Saleem, 2013). On the other hand, there 
is an extensive literature on patients’ experiences of US in prenatal screening and 
diagnosis, (Ahman et al., 2010; Lalor & Begley, 2006; Mitchell, 2004; Van der Zalm & 
Byrne, 2006). Social constructionism in particular is a key theoretical perspective that 
has helped shed light on key aspects of antenatal screening and testingxiv. Coinciding 
with the more explicit developing interest in the sociology of diagnosis (Jutel & 
Nettleton, 2010), the combined interest in diagnosis, medical imaging and the fetus as 
patient has prompted some fascinating and highly productive work on the use of iuMRI 
in pregnancy. Reed et al.’s work (2016; 2016) in particular is noteworthy in terms of 
how social constructionist accounts of pregnancy have been used to inform critical 
evaluation of this emerging technology. Practically speaking, the issues raised highlight 
the need for parents to be better prepared to face ‘bad’ news and ongoing uncertainty, 
and for clinicians to be more equipped to counsel patients. Our analysis suggests that 
the contribution of iuMRI is in providing improved information, not only to clinicians 
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but to parents as well, particularly if the visual data are made available to them. This is 
consistent with findings suggested in Reed et al (2016) that iuMR images can allow 
both the patient and the professional to navigate clinical uncertainty in a productive 
way. Our study of a wider sample of women adds to this work by providing insights 
into the patient experience of the physical discomforts of iuMRI and, in several cases, 
an emotional roller coaster during their prenatal diagnostic pathway. As such, it points 
to the importance of patient-professional interaction in healthcare where not only the 
emotional but the embodied needs of the patient are acknowledged.  
An established body of literature that ranges from critiques of philosophical 
interpretations of pregnancy, to feminist counter interpretations of the social realities of 
being pregnant testify to pregnancy as an embodied experience (Mullin, 2002). 
Neiterman (2012) claims that the physiological changes of pregnancy such as weight 
gain and sickness are neglected in most studies of pregnancy. In the literature on patient 
experiences of US and MRI, it is often the case that the physical condition of pregnancy 
is rarely mentioned, with the focus being on the mechanical and psychological effects of 
the scan. The physical and emotional ‘labour’ that women do in pregnancy such as 
dealing with nausea and vomiting, fatigue and physical pain is rendered ‘invisible’. This 
may be a result of a general belief that women are able or expected to bear pain better 
than men as part of their natural constitution (Bendelow & Williams, 1998). 
Alternatively, it may also be that the focus is on the fetus as a patient (Casper, 1998; 
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Duden, 1993; Harrison, Golbus, & Filly, 1990) and shifted away from the embodied 
experience of the pregnant woman. 
Following the idea that all human perception is embodied, this article highlights the 
patient experience of iuMRI for fetal brain abnormalities. Women and their partners on 
this pathway are full of expectation, anticipation and anxiety. As pregnant women they 
are experiencing numerous physiological changes and for some, physical discomfort. 
However, although pregnancy is often conceptualised as a site of legitimate medical 
intervention, notions of pregnancy have moved away from an illness model. In addition, 
the emergence of the fetus as an (unborn) patient introduces a tension in how clinicians 
deal with occasions where the needs of the two patients are in conflict (Casper, 1998). 
The interview data also illustrate the intimate and embodied interactions between the 
fetus and the patient relative to the physical effects of being in the MRI machine. The 
physical and emotional ‘invisible’ work that many pregnant women do extends to being 
the compliant patient and enduring the physical restraints of the scan machine, and 
keeping ‘nice and still’. This is because their overriding concern is the health of their 
unborn baby. In offering our interpretation of women’s accounts of their experiences of 
iuMRI, we aim to enhance existing understandings of women’s experiences of prenatal 
diagnosis.  
Much has been written about decision making in relation to termination of pregnancy 
following prenatal diagnoses (Benute et al., 2012; Bijma, van der Heide, & Wildschut, 
31 
 
2008; Werner-Lin et al., 2016). The main conclusions from these studies are that 
information from medical technologies can not only help inform but also complicate 
decision-making. MERIDIAN is a study of a technology that has yet to be rolled out 
across the NHS. In the light of existing studies, it is important to evaluate the impact of 
new fetal diagnostic procedures on pregnant women; it is their body that is subjected to 
any physical procedure, and within the options available under UK law, they are the 
primary decision makers about the future of the pregnancy in the context of a serious 
fetal abnormality.  
Drawing on these findings, we are able to offer insights into the experiences of pregnant 
women, prior to the formulation of further national or centralised NHS policy on this 
procedure. We conclude that the offer of a diagnostic MRI as an adjunct to US in the 
existing care pathway is well received by women and their partners, but the experience 
can be a big ‘ask’ in physical and emotional terms for many. While the research 
reported here is a limited study of women undergoing MRI at three sites, we are able to 
draw on the commonalities to highlight specific policy relevant themes. Firstly, many 
women are very willing to tolerate discomfort to try and resolve uncertainty because of 
what it can mean for decision making about the future of their baby. Secondly, in an 
information-hungry social context, women often feel that they have no choice but to 
tolerate uncertainty in prenatal diagnosis because of clinical and technological 
limitations. All this is in the context of the possibility of a termination which most 
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women understood to be legal only up to 24 weeks, not being aware that it is allowed 
for serious fetal abnormalities beyond this.xv Thus the role of the iuMRI in providing 
information and insight has to be seen within the context of this perceived time limit as 
well as some women’s preference to avoid amniocentesis. The question that could be 
asked is whether clinicians should recommend that women undergo an experience that 
can have such physical and emotional effects in order to come to a diagnosis. 
MERIDIAN has shown that there are many informational benefits from an iuMRI but 
care should be taken about assumptions that women will want to have the information 
regardless of the difficulties experienced during the scan.  
Clinical Implications 
The MERIDIAN study has shown that the iuMRI has significant utility with regards to 
diagnostic accuracy and for many women, the information from the MRI scan was 
perceived to be very helpful. What the qualitative sub-study results reveal however is 
that more could be done to improve women’s experience of iuMR imaging as part of the 
prenatal diagnosis pathway. This is ethically desirable because of the impact that 
emotional disturbance can have both on the patient as well as the fetus in utero (Ding et 
al., 2014; Dubber, Reck, Mueller, & Gawlik, 2015). Prior to undergoing iuMRI, it is 
important that health care providers take steps to reduce patient anxiety and 
acknowledge that some characteristics e.g. increased BMI, advanced gestation and 
pregnancy-related symptoms impact on the experience of MRI. Their briefing of women 
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should ideally include reassurances of the (minimal) effect that the machine can have on 
the fetus (Baker, Johnson, Harvey, Gowland, & Mansfield, 1994; Clements et al., 2000) 
and on the women themselves. During the scanning process, health care providers 
should be aiming to give women a patient-friendly experience (Duncan et al., 1996). 
On-going commentary during the scan can help allay fears and the presence of a 
supportive partner can help women cope better with discomfort, thereby increasing the 
likelihood of the scan being completed successfully. After the procedure, women 
appreciated having some idea of how the scan went, and when results could be 
expected. If these conditions were present, not only would they improve the patient 
experience but they would also acknowledge the embodied experience of pregnancy as 
well as the need for an equal focus on both mother and fetus within the fraught 
circumstances of having to make a life-changing decision.  
Concluding summary 
From a clinical perspective, our article has established the significance of iuMRI for the 
accurate diagnosis of fetal brain anomalies and in reassuring and/or satisfying parents’ 
needs for information regarding their developing child. While we have provided 
recommendations for improved practice, further research could be conducted into how 
useful our recommendations have been for both the clinical community and patient 
advocates. From an academic perspective, the use of iuMRI is a new and growing area 
of research, especially so in social science approaches to prenatal diagnosis. On this 
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specific topic, there is very little relating to decision making, both for clinicians and 
parents, making this a useful area for future research. As social constructionism is a key 
feature of medical sociology more generally and there is a significant amount of 
literature relating to the social construction of pregnancy, there is scope beyond this 
article to utilise this epistemology in further theoretical work on the impact of new 
scanning technologies in prenatal diagnosis.  
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i These methods include improved gradient performance in hardware and the development of 'ultrafast' 
sequences such as single shot Fast Spin Echo and Steady State acquisitions. 
ii We use the term intra uterine MRI (iuMR Imaging or iuMRI) to indicate that our research focuses on 
the experiences of women undergoing MR imaging of a live fetus in-utero. This term is used in 
preference to fetal MRI, which is a broader term encompassing other forms of MR imaging, such as 
imaging the fetus post mortem.    
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iii The cerebral ventricles are a communicating network of spaces in the brain filled with cerebral spinal 
fluid. Ventriculomegaly (VM), defined as a lateral ventricle width ≥10mm (Saleem, 2013), occurs in up 
to 2.5 per 1000 pregnancies and is one of the most common brain abnormalities detected (Hannon, 
Tennant, Rankin, & Robson, 2012). VM is associated with other structural abnormalities, such as spina 
bifida, chromosomal abnormalities, such as trisomy 21, and congenital infection. Where other central 
nervous system (CNS) abnormalities are found in conjunction with VM, there is a higher risk of poor 
outcome. 
iv The most common additional brain abnormality found with VM is agenesis of the corpus callosum 
(ACC) (Blaicher et al., 2003). The corpus callosum is the largest fibre tract in the CNS and connects the 
two cerebral hemispheres. 
v A rhythmic thumping noise is produced by a pump for liquid helium in the refrigeration system for the 
scanner. Women are offered headphones but not sedation.  
vi Much of the existing sociological work on antenatal testing has tended to see routine screening (e.g. 
ultrasound or blood tests) and specific diagnostic testing (e.g. iuMRI or amniocentesis) as parts of one 
broader phenomenon. Whilst we would agree that this body of work has been very productive for how 
understandings of visualising the fetus (Roberts, 2012) have developed, we offer a slightly different 
perspective on iuMRI in this article. Our analysis stems from a more explicit analytic distinction between 
the phenomenon of screening and the phenomenon of diagnostic imaging in pregnancy. This distinction is 
important when considering women’s experiences of their health care, because the risk-based decisions 
being made might be considered qualitatively distinct. Visualising the fetus in routine screening has 
become the norm and an accepted social event, whereas diagnostic imaging based on an identified 
anomaly is a rare occurrence and characterised by heightened anxieties particularly around the possibility 
of survival and decision-making about termination. Our work places this distinction centre-stage, and 
provides an analysis of women’s experiences in the context of this specific form of uncertainty, where the 
materiality of the anomaly is more tangible. 
vii Existing services have developed in areas that have idiosyncratic characteristics (for example, a 
specialist radiologist, and access to MRI equipment). 
viii This would, in part, potentially help address Williams et al’s concern (2006) about the speed with 
which technological changes are implemented without understanding the impact on user experiences. 
ix Given the expense associated with developing iuMRI care delivery, any national policy would need to 
encompass the existing variations in UK delivery to be economically viable.   
x The interviews were mainly conducted by Mabel Lie (41 interviews) except for a period of sick leave 
when Dr Emma Clavering conducted three interviews. 
xi This report presents independent research commissioned by the National Institute for Health Research 
(NIHR). The views and opinions expressed by the interviewees in this publication are those of the 
interviewees and do not necessarily reflect those of the authors, those of the NHS, the NIHR, MRC, CCF, 
NETSCC, the HTA programme or the Department of Health. 
xii See explanations of abbreviations in Table 1. 
xiii This piece of equipment contains radio frequency receiver coils to improve signal reception. 
xiv For example, social constructionist perspectives on disability to evaluate prenatal screening and 
prenatal diagnosis in relation to social expectations (e.g. Asch, (1999)) has highlighted how social 
contextual issues impact on women’s choices about diagnostic testing (e.g. Rapp (1998)). More recently, 
the debates about the socially constructed nature of antenatal testing in particular, and of pregnancy more 
generally, have developed to encompass a growing interest in embodiment in the social sciences. For 
example, Williams’ (2006) milestone work analyses routine antenatal screening and innovative fetal 
surgery as parts of the same shift toward the construction of the fetus as patient. The literature on visual 
representations in antenatal testing are informed by a broader literature on visualisation and technology, 
and for MRI, Joyce’s (2005, 2006) work has been seminal.  
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xv In the UK, decisions about whether a specific fetal anomaly is a legitimate basis for termination of 
pregnancy on the grounds of fetal anomaly fall within the jurisdiction of clinical opinion, rather than there 
being a codified list of anomalies. Two clinicians with relevant expertise must agree that the requirement 
is met for any termination of pregnancy for fetal anomaly before the termination is permitted.  
